Member Info for Bridges

Totally agree mufta. The TO thermometer is in the red zone !!!!

Thanks Thoth2 ; recent example of Gilead deal: USD 21 Billion for immunomedics. They have a new leadership team that is focused on doing deals and looking to become an oncology powerhouse, the deals are linked to access into experimental cancer drugs. Thoth you have been saying this for a long time now and Gilead seem to be looking for Sareum type companies. could Sareum be the first purchase of 2021?

Imho TO now looking closer than ever and would say imminent. Why? Literally as every day goes by SAR becomes more valuable. Since last Thursday the value has significantly increased. GLA

Type this in ..... “covid 19 tyk2”

Gate open double time on Sundays ;)

Just logged on to see this brilliant analogy. See you at the party and let’s all vomit!!!

They are first result now :)

Andy I agree and you know as well as I and many others on this board that the mm “job” is to make markets and create liquidity. The issue here is that they are not doing their job. IMHO The MM / Brokers have forward sold. The more they drive price down the more money they make acquiring the shares at below market prices. Brokers also get fees and likewise with advisors who also make commission. The problem with AIM and offbook trades is that for PIs it is difficult to predict what the outcome will be. There has However been clear evidence of manipulating the share price down via various know tactics that when analysing the trades and margin over the past you can see the game being played; it could t be more obvious if they tried. Is this forward selling with or without the knowledge of the BOD?

The only detrimental effect just4fun at 3p was the brokers and MM looking for shares to forward selling. I guess they didn’t find many but took them anyway ; )

A lot of water under the bridge since June 2020, the date of the Marten and Co report. Most importantly and with the most intrinsic value not accounted for is the event that happened after that report was written. US Patent Allowance for TYK2/JAK1 inhibitor the core commercial value not price in at all. Plus the COVID grant award that allows the fast track of the same. Conculsion the report is out of date and therefore has no relevance to the value and future value of SAR.
Share price is normally priced at a future value 6 to 12 months in advance and of the now, the now lags behind. What will the value be of SAR in 6 months from now? This is where the share price should be heading and tat is the prob;em that I have with the MM blatant manipulation of the SP, the NOMAD and the in capabilities of Citygate. Change citygate and change the NOMAD.

Reports of people getting allergic reaction to the Pfizer BioNTec jab, and UK regulator issuing warning that people with a history or allergic reactions not to have the jab!

I get it Lordlush just think it needs to be called out.

Yes it matters Lordlush it’s a matter of principle this is pure manipulation. If the MM were concentrating on making liquidity instead of unwieldy ding their short position then we would be higher. Awuful smell

Seems Nana won! Now lets look forward to the meetings in London, when is the question. The bod need to confirm now when this will happen!

The 32k from 7/12 is definitely a buy.

Another large late reported buy today. Thoth2, could be an east position being built on the cheap.

https://www.graphic.com.gh/elections/

Thanks for the update freeshare, still neck and neck in elections. Keeping a firm eye on the results

EC to declare presidential results today . Let’s see who wins that will determine who and when they will meet, when did you receive they comms freeshare?

Neck and neck